Health & Safety Industry Today

Cancer Therapeutics Market to Reach US$ 531,538.02 Million by 2031, Growing at 12.8% CAGR

According to BMI; The cancer therapeutics market size is expected to reach US$ 5,31,538.02 million by 2031 from US$ 2,30,423.56 million in 2024. The market is estimated to record a CAGR of 12.8% from 2025 to 2031.
Published 03 February 2026

The Cancer Therapeutics Market continues to evolve rapidly, driven by groundbreaking advancements in targeted therapies, immunotherapy, and personalized medicine that are transforming patient outcomes worldwide. Leading pharmaceutical innovators and healthcare organizations are collaborating to address unmet needs in oncology, fostering hope for millions affected by cancer therapeutics challenges.

Industry experts highlight how recent regulatory approvals and clinical breakthroughs are accelerating access to effective cancer therapeutics solutions. These developments underscore a shift toward precision oncology, where treatments are tailored to individual genetic profiles for better efficacy and fewer side effects.

Executive Summary and Global Market Analysis:

Cancer therapeutics encompasses a multitude of treatments that focuses on managing or curing cancer. The treatments metrics often used are chemotherapy, radiation, immunotherapy, targeted therapy, hormone therapy, surgery, and stem cell therapy. All of these strategies intend to remove or manage the complexity of the cancer cells, symptoms, and enhancing the overall survival of a patient. Depending on the type and stage of cancer a patient is in along with their general health, multiple types of treatments are often used to maximize the effectiveness of the therapy.

One of the primary drivers of the market is the growing burden of breast and lung cancer driving cancer therapeutics market. With the rise in breast and lung cancer cases, there is an increasing need for effective and targeted therapies to improve patient outcomes, which has led to a surge in research and development activities in cancer therapeutics. Therefore, the growing burden of breast and lung cancer drives the cancer therapeutics market. Similarly, the surging investments in oncology research, is another key contributor, research and development activities have become the foundation for discovering innovative drugs and therapeutic strategies with the rising demand for more effective and targeted cancer therapies.

Check valuable insights in the Cancer Therapeutics Market report. You can easily get a sample PDF of the report - https://www.businessmarketinsights.com/sample/BMIRE00031299

Cancer Therapeutics Market Drivers and Opportunities:

Growing Burden of Breast and Lung Cancer Driving Cancer Therapeutics Market

As per the World Health Organization's media center, different types of cancer cause ~1 in every 6 deaths across the world. There were ~20 million new cancer cases and 9.7 million deaths associated with the disease in 2022; the burden is projected to increase by ~77% by 2050, further straining health systems and communities. According to the American Cancer Society, genes inherited from parents are responsible for 5–10% of all cancers. Numerous genes that are associated with the predisposition of people to cancer have been identified. For example, the risk of developing various cancers, including breast, ovarian, and prostate cancer, increases with mutations in the inherited cancer predisposition genes BRCA1 and BRCA2. Breast cancer is deemed as the most prevalent cancer among women, with a continuously rising incidence worldwide. The increasing incidence of the disease is attributed to a number of risk factors, including environmental impact, genetic susceptibility, hormone imbalances, and changes in lifestyle. In addition, breast cancer is among the most prevalent cancers in the US. According to an estimate published by Breastcancer.org in January 2022, 1 in 8 women in the country (i.e., ~13%) will have invasive breast cancer at some point in their lives. The same source predicts that 51,400 new cases of noninvasive (in situ) breast cancer and 287,850 new occurrences of invasive breast cancer would be reported among women in the US in 2022. Further, it is projected that the nation will see about 2,710 more cases of invasive breast cancer in men that same year. 1 in 833 males may have breast cancer at some point in their lives. With the rise in breast cancer cases, there is an increasing need for effective and targeted therapies to improve patient outcomes, which has led to a surge in research and development activities in cancer therapeutics. Therefore, the growing burden of breast cancer drives the cancer therapeutics market.

Increased Support from Government and Private Organizations

Governments of various countries across the world recognize the importance of having a potent cancer treatment landscape and are implementing policies to improve access to effective treatments. Many governments and private organizations have increased funding for research and development in cancer therapeutics, resulting in the development of innovative drugs and therapies. For instance, Susan G. Komen, the leading cancer charity in the world, recently announced 49 new grants that are to be awarded to scientists from 28 prestigious universities across the US. Through the US$ 19.3 million offered in new grants, Komen continues to assist the next generation of diverse leaders in breast cancer research while providing support through two areas of focus—advancing precision medicine and eradicating disparities in breast cancer outcomes. Such a rise in investments in research allows pharmaceutical companies to explore new treatment options and develop highly targeted as well as effective therapies for cancer patients.

Cancer Therapeutics Market Report Coverage and Deliverables

The "Cancer Therapeutics Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

Cancer therapeutics market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

Cancer therapeutics market trends, as well as market dynamics such as drivers, restraints, and key opportunities

Detailed Porter's Five Forces and SWOT analysis

Cancer therapeutics market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments

Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the cancer therapeutics market

Detailed company profiles

Get Premium Research Report of Cancer Therapeutics Market Size and Growth Report at: https://www.businessmarketinsights.com/buy/BMIRE00031299

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

Contact us:

  • If you have any questions about this report or would like further information, please contact us:
  • Contact person: Ankit Mathur
  • Email: sales@businessmarketinsights.com
  • Phone: +16467917070

Other Industry News

Ready to start publishing

Sign Up today!